The Latest Medical News

A Summary of The Latest Medical News: Perimenopause—the 3–10 years before your final menstrual period—is marked by fluctuating and then steadily falling estrogen levels. Because estrogen has favorable effects on blood vessels, lipids and glucose metabolism, its decline during this transition tends to accelerate the development of cardiovascular risk factors. Recent research is calling perimenopause a potential “window of opportunity” to intervene before absolute risk climbs further after menopause. Key points and practical take-aways: 1. Why cardiovascular risk rises in perimenopause • Estrogen decline promotes: – A less favorable lipid profile (higher LDL, lower HDL) – Increased central fat accumulation and insulin resistance – Higher blood pressure via changes in vascular tone • These shifts can accelerate atherosclerosis years before a first heart attack or stroke. 2. What makes it a window of opportunity • Risk factor changes begin in perimenopause but often go unrecognized. • Early identification means interventions may be more effective at slowing or reversing arterial changes. • Waiting until after menopause can miss this more modifiable phase. 3. Screening during perimenopause • Annual blood pressure measurement. • Lipid panel every 1–3 years (more often if borderline or additional risk factors). • Fasting glucose or HbA1c to assess insulin resistance or diabetes risk. • Body‐mass index (BMI), waist circumference. • Lifestyle assessment: diet quality, physical activity, smoking, alcohol. 4. Lifestyle interventions • Diet: Emphasize vegetables, fruit, whole grains, lean protein, healthy fats (Mediterranean-style). • Exercise: ≥150 minutes/week of moderate aerobic activity plus resistance training twice weekly. • Weight management: Even 5–10 percent weight loss can improve lipids and insulin sensitivity. • Smoking cessation and moderation of alcohol. • Stress reduction (yoga, mindfulness), as chronic stress worsens cardiometabolic health. 5. Role of hormone therapy (HT) • When started within 10 years of menopause onset (or before age 60), HT may have neutral or modestly beneficial effects on cardiovascular outcomes in healthy women with symptoms. • Not indicated solely for heart protection; individualized risk–benefit discussion is essential. • Contraindications include uncontrolled hypertension, active liver disease, history of estrogen-sensitive cancer, or thromboembolic disorders. 6. Other preventive therapies • Low-dose aspirin: Consider only if long-term risk of cardiovascular disease clearly outweighs bleeding risk (typically in older postmenopausal women with high 10-year risk). • Statins: May be appropriate for women with elevated LDL cholesterol or other risk enhancers per current guidelines. • Blood pressure control: Treat to target (<130/80 mm Hg for most). Bottom line: Perimenopause is more than just irregular periods and hot flashes—it’s a phase when cardiovascular risk factors can accelerate. By recognizing and addressing blood pressure, lipids, glucose metabolism and lifestyle habits early in this transition, you can substantially reduce your long-term risk of heart disease and stroke. If you’re in perimenopause (or approaching it), talk with your clinician about a tailored cardiovascular-risk evaluation and prevention plan. Help with your insurance? https://tally.so/r/n012P9